Nolan Sean P. Insider Trades

Insider Trading History

Track insider trading activity for Nolan Sean P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ventas
Ventas VTR
Director
Holding Value $2.07M 26,181 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 2,047 shares
$90.35
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $17.1M 2,908,257 shares
Last Trade
Jan 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$190k 41,312 shares
$4.61
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $17.4M 2,949,569 shares
Last Trade
Jan 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$650k 136,789 shares
$4.75
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $18.2M 3,086,358 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.05M 1,656,000 shares
$4.86
$5.89
Ventas
Ventas VTR
Director
Holding Value $1.91M 24,134 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 2,882 shares
$64.18
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $12.2M 2,078,358 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 892,500 shares
$1.85
$5.89
Ventas
Ventas VTR
Director
Holding Value $1.68M 21,252 shares
Last Trade
May 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 3,648 shares
$47.96
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $6.98M 1,185,858 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.05M 2,369,376 shares
$1.71
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $2.75M 466,550 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$723k 466,550 shares
$1.55
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $9.04M 1,535,545 shares
Last Trade
Aug 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$858k 444,444 shares
$1.93
$5.89
Ventas
Ventas VTR
Director
Holding Value $1.39M 17,604 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 3,835 shares
$45.63
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Chief Executive Officer
Holding Value $6.52M 1,106,131 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 1,106,131 shares
$2.26
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $91.3k 15,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.1k 31,000 shares
$2.81
$5.89
Ventas
Ventas VTR
Director
Holding Value $1.09M 13,769 shares
Last Trade
Apr 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 3,056 shares
$57.25
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $91.3k 15,500 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$388k 15,500 shares
$25.04
$5.89
Ventas
Ventas VTR
Director
Holding Value $847k 10,713 shares
Last Trade
May 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 3,158 shares
$55.40
$79.10
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $6.89k 1,170 shares
Last Trade
May 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.1k 1,170 shares
$22.35
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $0 0 shares
Last Trade
Sep 28, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$23.7M 1,001,470 shares
$23.69
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $6.43M 1,091,101 shares
Last Trade
Sep 28, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$25.8M 1,091,101 shares
$23.69
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $183k 31,000 shares
Last Trade
Sep 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up